On the other hand, mutations activating both canonical downstream signaling pathways, PI3K/AKT and RAS/RAF/MEK/ERK, occur frequently in human cancers and have been implicated in the pathogenesis of T-ALL[12, 13]. This evidence concerns the gene MAP2K7 and acute lymphoblastic leukemia.